Process View
Any process that activates or increases the frequency, rate, or extent of homotypic cell-cell adhesion.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of homotypic cell cell adhesion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.997 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.997 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.989 | ||
| IL8 | interleukin 8 | 0.981 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.958 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.957 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.942 | ||
| IL1B | interleukin 1, beta | 0.913 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.911 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.891 | Human | |
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.884 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.837 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.775 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.773 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.764 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.697 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.555 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.543 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.510 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.490 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.453 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.447 | ||
| SRGN | serglycin | 0.424 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.354 | ||
| MSN | moesin | 0.351 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.340 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 0.283 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.274 | ||
| IDE | insulin-degrading enzyme | 0.271 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.270 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.231 | Human | |
| PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.225 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.212 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.166 | ||
| IFNG | interferon, gamma | 0.158 | ||
| BCL2A1 | BCL2-related protein A1 | 0.149 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.148 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.145 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.144 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.138 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.136 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.132 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.114 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.106 | ||
| CD69 | CD69 molecule | 0.103 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.101 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 0.095 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.094 | Human | |
| IL18RAP | interleukin 18 receptor accessory protein | 0.093 | ||
| CD83 | CD83 molecule | 0.092 | ||
| INHBA | inhibin, beta A | 0.092 | ||
| PLAU | plasminogen activator, urokinase | 0.090 | ||
| SELE | selectin E | 0.087 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.085 | Human | |
| C1orf93 | chromosome 1 open reading frame 93 | 0.081 | ||
| CH25H | cholesterol 25-hydroxylase | 0.079 | ||
| TNF | tumor necrosis factor | 0.070 | ||
| UBD | ubiquitin D | 0.069 | ||
| IL7R | interleukin 7 receptor | 0.064 | ||
| FNBP1 | formin binding protein 1 | 0.064 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.061 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.060 | Human | |
| IL2RB | interleukin 2 receptor, beta | 0.060 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.060 | ||
| CD2 | CD2 molecule | 0.059 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.057 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.057 | Human | |
| ITK | IL2-inducible T-cell kinase | 0.055 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.054 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.052 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.048 | ||
| SLAMF7 | SLAM family member 7 | 0.045 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.044 | Human | |
| EZR | ezrin | 0.041 | ||
| GNLY | granulysin | 0.037 | ||
| TLR2 | toll-like receptor 2 | 0.037 | ||
| TNC | tenascin C | 0.036 | ||
| IL10 | interleukin 10 | 0.036 | ||
| KYNU | kynureninase | 0.034 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.034 | ||
| C1S | complement component 1, s subcomponent | 0.032 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.032 | ||
| SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 0.031 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.031 | ||
| FPR3 | formyl peptide receptor 3 | 0.031 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.030 | ||
| PACSIN2 | protein kinase C and casein kinase substrate in neurons 2 | 0.030 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.030 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.029 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.029 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.027 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.027 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.026 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.025 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.025 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.025 | ||
| SLAMF8 | SLAM family member 8 | 0.025 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.025 | ||
| OSMR | oncostatin M receptor | 0.024 | ||
| THBS1 | thrombospondin 1 | 0.023 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.023 | ||
| SNX33 | sorting nexin 33 | 0.022 | ||
| LMO4 | LIM domain only 4 | 0.022 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.022 | ||
| FAP | fibroblast activation protein, alpha | 0.022 | ||
| TNKS | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase | 0.022 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.022 | ||
| MSC | musculin | 0.021 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.021 | ||
| IL1A | interleukin 1, alpha | 0.021 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.021 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.021 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.021 | ||
| GPR109B | G protein-coupled receptor 109B | 0.021 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.020 | ||
| PTX3 | pentraxin 3, long | 0.020 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.020 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.019 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.019 | ||
| AQP9 | aquaporin 9 | 0.019 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.019 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.019 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.019 | ||
| IL32 | interleukin 32 | 0.019 | ||
| G0S2 | G0/G1switch 2 | 0.018 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.018 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.018 | ||
| DDX39A | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A | 0.018 | ||
| IER3 | immediate early response 3 | 0.018 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.018 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.017 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.017 | ||
| PLEK | pleckstrin | 0.017 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.017 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.016 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.016 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.016 | ||
| DARC | Duffy blood group, chemokine receptor | 0.016 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.016 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.016 | ||
| SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.015 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.015 | Human | |
| TAGLN2 | transgelin 2 | 0.015 | ||
| PDPN | podoplanin | 0.015 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.015 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.015 | ||
| IL21R | interleukin 21 receptor | 0.014 | ||
| FOSL1 | FOS-like antigen 1 | 0.014 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.014 | ||
| STK17B | serine/threonine kinase 17b | 0.014 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.014 | ||
| C2 | complement component 2 | 0.014 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.014 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.013 | ||
| EMP1 | epithelial membrane protein 1 | 0.013 | ||
| SNX9 | sorting nexin 9 | 0.013 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.013 | ||
| CD80 | CD80 molecule | 0.013 | ||
| NNMT | nicotinamide N-methyltransferase | 0.013 | ||
| RGS4 | regulator of G-protein signaling 4 | 0.013 | ||
| SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | 0.012 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.012 | ||
| MPP4 | membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) | 0.012 | ||
| VCAN | versican | 0.012 | ||
| SPP1 | secreted phosphoprotein 1 | 0.012 | ||
| NKG7 | natural killer cell group 7 sequence | 0.012 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.012 | ||
| C3AR1 | complement component 3a receptor 1 | 0.012 | ||
| FRZB | frizzled-related protein | 0.012 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.011 | ||
| TPM4 | tropomyosin 4 | 0.011 | ||
| IL11 | interleukin 11 | 0.011 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.011 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.011 | ||
| GPR84 | G protein-coupled receptor 84 | 0.011 | ||
| APOC1 | apolipoprotein C-I | 0.011 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.011 | ||
| BID | BH3 interacting domain death agonist | 0.010 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.010 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.010 | ||
| C5AR1 | complement component 5a receptor 1 | 0.010 | ||
| TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.010 | ||
| TLR3 | toll-like receptor 3 | 0.010 |